First Clinical Trial Under Novartis' Beacon of Hope Set to Launch

The first clinical trial under Novartis’s 10-year, multimillion dollar Beacon of Hope collaboration with 26 Historically Black Colleges is set to launch at Morehouse School of Medicine.

Morehouse is the first institution to establish a clinical trial center of excellence under the Beacon of Hope program, which seeks to address systemic health disparities across the research and medical development ecosystem and increase diversity in clinical trial participants and investigators.

The Morehouse Center’s first clinical trial is in LDL-C management, key to addressing a high coronary heart disease mortality rate among African Americans.